Pure Global
NCT06261034

A Study of Sex Differences in Neurocirculatory Control

Sex Differences in Neurocirculatory Control With Obstructive Sleep Apnea
Mayo Clinic·ClinicalTrials.govNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Obstructive Sleep Apnea
Study type
Observational
Sponsor & location
Primary sponsor
Mayo Clinic
Location
Rochester, United States of America
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2024
End date
Mar 01, 2027
Enrollment
60 participants
Primary outcome

Blood pressure,Arterial stiffness,Endothelial function

Summary

The purpose of this study is to investigate potential sex differences in neurocirculatory
 control of blood pressure in patients with untreated obstructive sleep apnea (OSA).

ICD-10 classifications
Sleep apnoeaSleep disordersSleep disorder, unspecifiedPrimary sleep apnoea of newbornNonorganic sleep disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06261034
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06261034 through Pure Global AI's free database. This phase not specified trial is sponsored by Mayo Clinic and is currently Not yet recruiting. The study focuses on Obstructive Sleep Apnea. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.